# Antekang Cheng

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antekang-cheng

- Industry: Medical Devices & Equipment
- Headquarters: Changsha, China
- Website: www.atkc.com.cn
- Latest round: Series A (Jul 1, 2020)
- Investors on record: 2

## About

Established in 2017 and based in Changsha, China, Antekang Cheng is a tumor electric field therapy technology developer, providing a tumor electric field therapy system suitable for Chinese patients.

The company’s main business is the research, development, and application of tumor electric field therapy technology. The company’s self-developed product is a personalized tumor electric field therapy system. Its products are used in the field of treating various cancers, such as ovarian cancer, pancreatic cancer, and lung cancer. By generating alternating electric fields of specific frequencies, waveforms, and field strengths in the tumor area, the system effectively inhibits tumor cell growth and promotes tumor cell death.

The company generates revenue by providing tumor electric field therapy equipment sales, technical services for the operation of the equipment, and cooperation with hospitals for clinical applications. It also earns from licensing its core technologies and intellectual property rights to relevant partners.

## Funding rounds

- Series A, Jul 1, 2020 — YuanBio Venture, Furong Capital

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Series A